Literature DB >> 1606740

Neopterin release from human endothelial cells is triggered by interferon-gamma.

S E Andert1, A Griesmacher, A Zuckermann, M M Müller.   

Abstract

Human umbilical vein endothelial cells (HUVEC) were investigated for their ability to produce neopterin, a biochemical marker for an activated immune system. Interferon-gamma (IFN-gamma), IL-1 alpha, IL-2, IL-6, tumour necrosis factor-alpha, granulocyte/macrophage colony stimulating factor, phytohaemagglutinin and concanavalin A were used to stimulate HUVEC. While IFN-gamma induced neopterin release from HUVEC in a time- and dose-dependent manner, all the other cytokines used had no effect on neopterin production. High neopterin levels are found in patients with rejection episodes or infections. Our results suggest that not only monocytes and macrophages, which are known to synthesize neopterin, but also endothelial cells are responsible for these high serum neopterin levels.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1606740      PMCID: PMC1554513          DOI: 10.1111/j.1365-2249.1992.tb06486.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Immune interferon enhances the production of interleukin 1 by human endothelial cells stimulated with lipopolysaccharide.

Authors:  P Miossec; M Ziff
Journal:  J Immunol       Date:  1986-11-01       Impact factor: 5.422

2.  Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers.

Authors:  D E Cavender; D O Haskard; B Joseph; M Ziff
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

3.  Cytokine regulation of interleukin 6 production by human endothelial cells.

Authors:  M R Shalaby; A Waage; T Espevik
Journal:  Cell Immunol       Date:  1989-07       Impact factor: 4.868

4.  Interferon-gamma enhances biosynthesis of pterins in peripheral blood mononuclear cells by induction of GTP-cyclohydrolase I activity.

Authors:  G Schoedon; J Troppmair; G Adolf; C Huber; A Niederwieser
Journal:  J Interferon Res       Date:  1986-12

5.  Biosynthesis and metabolism of pterins in peripheral blood mononuclear cells and leukemia lines of man and mouse.

Authors:  G Schoedon; J Troppmair; A Fontana; C Huber; H C Curtius; A Niederwieser
Journal:  Eur J Biochem       Date:  1987-07-15

6.  Cultured human vascular endothelial cells acquire adhesiveness for neutrophils after stimulation with interleukin 1, endotoxin, and tumor-promoting phorbol diesters.

Authors:  R P Schleimer; B K Rutledge
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

7.  Interleukin 1 stimulates human endothelial cells to produce granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor.

Authors:  V C Broudy; K Kaushansky; J M Harlan; J W Adamson
Journal:  J Immunol       Date:  1987-07-15       Impact factor: 5.422

8.  Tumour necrosis factor-alpha and lipopolysaccharide enhance interferon-induced tryptophan degradation and pteridine synthesis in human cells.

Authors:  G Werner-Felmayer; E R Werner; D Fuchs; A Hausen; G Reibnegger; H Wachter
Journal:  Biol Chem Hoppe Seyler       Date:  1989-09

9.  Neopterin as a new marker to detect acute rejection after heart transplantation.

Authors:  M Havel; A Laczkovics; H Teufelsbauer; M M Müller; E Wolner
Journal:  J Heart Transplant       Date:  1989 Mar-Apr

10.  Inhibition of endothelial cell proliferation by gamma-interferon.

Authors:  R Friesel; A Komoriya; T Maciag
Journal:  J Cell Biol       Date:  1987-03       Impact factor: 10.539

View more
  9 in total

1.  Modest correlation between serum neopterin levels and Gensini scores in a cohort of patients undergoing coronary angiography.

Authors:  C Özbek; I Baran; A Tütüncü; T Kuştarcı; K Karaağaç; A Özbek
Journal:  Ir J Med Sci       Date:  2013-08-29       Impact factor: 1.568

2.  Urinary neopterin: an immune activation marker in mesangial proliferative glomerulonephritis.

Authors:  Kazuyuki Ueno; Masaki Shimizu; Tadafumi Yokoyama; Sayaka Ishikawa; Yuko Tasaki; Natsumi Inoue; Naotoshi Sugimoto; Kazuhide Ohta; Akihiro Yachie
Journal:  Clin Exp Nephrol       Date:  2014-05-25       Impact factor: 2.801

3.  The Roles of Immunity in the Prevention and Evolution of Pulmonary Arterial Hypertension.

Authors:  Mark R Nicolls; Norbert F Voelkel
Journal:  Am J Respir Crit Care Med       Date:  2017-05-15       Impact factor: 21.405

Review 4.  Review: The Development of Risk Factors and Cytokines in Retinal Vein Occlusion.

Authors:  Yi Tang; Yan Cheng; Shuo Wang; Yongjie Wang; Pengjia Liu; Hong Wu
Journal:  Front Med (Lausanne)       Date:  2022-06-15

5.  Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products.

Authors:  K L Lim; A C Jones; N S Brown; R J Powell
Journal:  Ann Rheum Dis       Date:  1993-06       Impact factor: 19.103

6.  The diagnostic role and dynamic changes in cerebrospinal fluid neopterin during treatment of patients with primary central nervous system lymphoma.

Authors:  Mingying Geng; He Xiao; Jiaqi Liu; Yang Song; Ping Fu; Xing Cheng; Jinwei Zhang; Ge Wang
Journal:  Cancer Med       Date:  2018-07-07       Impact factor: 4.452

7.  Comparison between plasma neopterin and the urine neopterin:creatinine ratio as inflammatory biomarkers.

Authors:  Bianca Thomas; Priyesh Bipath; Margaretha Viljoen
Journal:  Afr Health Sci       Date:  2019-09       Impact factor: 0.927

8.  Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2.

Authors:  Tatyana Novoyatleva; Nabham Rai; Baktybek Kojonazarov; Swathi Veeroju; Isabel Ben-Batalla; Paola Caruso; Mazen Shihan; Nadine Presser; Elsa Götz; Carina Lepper; Sebastian Herpel; Grégoire Manaud; Frédéric Perros; Henning Gall; Hossein Ardeschir Ghofrani; Norbert Weissmann; Friedrich Grimminger; John Wharton; Martin Wilkins; Paul D Upton; Sonja Loges; Nicholas W Morrell; Werner Seeger; Ralph T Schermuly
Journal:  Commun Biol       Date:  2021-08-24

Review 9.  Immunomodulatory properties of cacao extracts - potential consequences for medical applications.

Authors:  Kathrin Becker; Simon Geisler; Florian Ueberall; Dietmar Fuchs; Johanna M Gostner
Journal:  Front Pharmacol       Date:  2013-12-12       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.